Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal carcinoma

Medical Journal of Australia

Volumn 187, Issue 5, 2007, Pages 274-277

  Viiala, Charlie H ^a   Olynyk, John K ^a,b  

^a FREMANTLE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CLINICAL TRIAL; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COMMUNITY PROGRAM; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SIGMOIDOSCOPY; SYMPTOM; ANALYSIS OF VARIANCE; COLORECTAL TUMOR; FOLLOW UP; MASS SCREENING; MIDDLE AGED; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

AGED; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; WESTERN AUSTRALIA;

EID: 34848851378     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb01241.x     Document Type: Article

References (22)

1. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia 2001. Canberra: AIHW, 2004. http://www.aihw.gov.au/publications/can/ca01/ca01.pdf (accessed Jul 2007).
2. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-437.
3. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Sydney: The Cancer Council Australia and the Australian Cancer Network, 2005.
4. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-657.
5. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-1575.
6. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291-1300.
7. Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy" - SCORE. J Natl Cancer Inst 2002; 94: 1763-1772.
8. Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005; 97: 989-997.
9. Olynyk JK, Aquilia S, Fletcher DR, Dickinson JA. Flexible sigmoidoscopy screening for colorectal cancer in average-risk subjects: a community-based pilot project. Med J Aust 1996; 165: 74-76.
10. Collett JA, Olynyk JK, Platell CF. Flexible sigmoidoscopy screening for colorectal cancer in average-risk people: update of a community-based project. Med J Aust 2000; 173: 463-466.
11. The Multicentre Australian Colorectal-neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust 2006; 184: 546-550.
12. Segnan N, Senore C, Andreoni B, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007; 132: 2304-2312.
13. Morris M, Iacopetta B, Platell C. Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals. Med J Aust 2007; 186: 296-300.
14. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343: 162-168.
15. Lin OS, Schembre DB, McCormick SE, et al. Risk of proximal colorectal neoplasia among asymptomatic patients with distal hyperplastic polyps. Am J Med 2005; 118: 1113-1119.
16. Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005; 352: 2061-2068.
17. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129: 422-428.
18. Bressler B, Paszat LF, Vinden C, et al. Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology 2004; 127: 452-456.
19. Bampton PA, Sandford JJ, Cole SR, et al. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Gut 2005; 54: 803-806.
20. Pabby A, Schoen RE, Weissfeld JL, et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc 2005; 61: 385-391.
21. Ee HC, Semmens JB, Hoffman NE. Complete colonoscopy rarely misses cancer. Gastrointest Endosc 2002; 55: 167-171.
22. Threlfall TJ, Thompson JR. Cancer incidence and mortality in Western Australia, 2005. Perth: Department of Health, Western Australia, 2007. (Statistical series No. 81.)